𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy

✍ Scribed by Barlési, F; Tchouhadjian, C; Doddoli, C; Torre, J-P; Astoul, P; Kleisbauer, J-P


Book ID
109998350
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
64 KB
Volume
92
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES